Canes...I am willing to wait two years, but only if a new EPA product, such a FDC(preferably with MND-2119 and a statin), can be introduced into the U.S. with the advantage of patent exclusivity....That can be done only if Amarin is sold to a BP.
The dream of Amarin GIA and becoming a BP, by itself, ended with the judge Du decision.
The dream lives on with current management, but it is only a mirage.